mutation

Documents about mutation

• Somatic mutation profiles in aged military nuclear test veterans: A comparative whole-genome sequence study#327596PLOS
• Niraparib, Abiraterone Acetate and Prednisone for mHSPC With Deleterious Homologous Recombination Repair Alterations#888868ClinicalTrials.gov
• Management of Women With BRCA1/2 Mutation#912349ClinicalTrials.gov
• What sets the mutation rate of a cell type in an animal species?#269675PLOS
• K-Basket, Avelumab, Biomarker-driven, Advanced Solid Tumor#851147ClinicalTrials.gov
• Cohort of Tumors With POLE/D1 Mutation#346923ClinicalTrials.gov
• Low frequency variants can predetermine antiviral drug resistance development in herpes simplex virus type 1#269673PLOS
• Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers#880113ClinicalTrials.gov
• Prostate Cancer Genetic Risk Evaluation and Screening Study#801081ClinicalTrials.gov
• A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations#904116ClinicalTrials.gov
• POETIG Trial - POnatinib After rEsisTance to Imatinib in GIST#890358ClinicalTrials.gov
• Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy#903024ClinicalTrials.gov
• Dietary Intervention and BRCA Penetrance#810114ClinicalTrials.gov
• SuperSelective PCR primers for determining <i>cis/trans</i> configurations of mutations within the same gene#197007PLOS
• Circulating Tumor DNA and Follow-up of BRCA1 Mutation Carriers (CirCa 01)#856970ClinicalTrials.gov
• Molecular Profiling in Prostate Cancer#837349ClinicalTrials.gov
• A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)#812612ClinicalTrials.gov
• A Phase 2 Study of Ivosidenib in Previously Treated Japanese Subjects With Nonresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation#812394ClinicalTrials.gov
• Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives#914106ClinicalTrials.gov
• Mutation count and mutation profile analyses of single-nucleotide variants in single human colon crypts#363386bioRxiv / medRxiv
• BRCA Main Home Nutritional Intervention-random Study#829281ClinicalTrials.gov
• Formation professionnelle et mutation identitaire : le cas des chefs d’établissement français#7938HAL (France)
• The Role of POLE Mutation in High Risk Endometrial Cancer.#810282ClinicalTrials.gov
• Genetic Education in BRCA Families#838961ClinicalTrials.gov
• NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial#172314ClinicalTrials.gov
• Statistical method for testing the neutral mutation hypothesis by DNA polymorphism.#6773OpenAlex
• Driver mutation impact in Chinese hepatocellular carcinoma#483566PLOS
• Human Mutation/substitution Rate: Variability, Modeling And Applications#648092ScholarlyCommons at Penn
• Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or Recurrent Ovarian Cancer Patients With Germline Mutation.#805689ClinicalTrials.gov
• CPAP in Treating Obstructive Sleep Apnea in Patients With Polycythemia Vera or Essential Thrombocythemia#892488ClinicalTrials.gov
• Study on the Efficacy and Safety of VA Regimen Compared to "3+7" Regimen in Newly Diagnosed AML With NPM1 or IDH1/IDH2 Mutations#893818ClinicalTrials.gov
• Mutation-preserving generalized cluster algebras and Laurent mutation invariants#633629arXiv (OAI Expanded)
• Mutation-preserving generalized cluster algebras and Laurent mutation invariants#635978arXiv (All)
• ALK Inhibitor in Metastatic Colorectal Cancer With ALK Mutation.#805014ClinicalTrials.gov
• CPET in CF Patients With One G551D Mutation Taking VX770#854269ClinicalTrials.gov
• Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer#862225ClinicalTrials.gov
• Ibrutinib Combined With Rituximab for Treatment of Relapsed Refractory MYD88 and CD79A/B (or CD79B Alone) DLBCL Who Have Received at Least Two Prior Therapies#910790ClinicalTrials.gov
• Semantical Mutation, Algorithms and Programs#116801PhilArchive
• Dent Disease Mutation Genotyping#311057ClinicalTrials.gov
• A disease concept model for GABRB3-related neurodevelopmental disorders#359010RUcore, Rutgers University Community Repository
• EGFR-TKIs Combine Chemotherapy as First-line Therapy for Patients With Advanced EGFR Mutation-positive NSCLC#832710ClinicalTrials.gov
• Dasatinib Combined With Chemotherapy in Relapsed t(8;21) Acute Myeloid Leukemia With KIT D816 Mutation#885820ClinicalTrials.gov
• Integrated Genomics in Oncogene-driven NSCLC With Acquired Resistance#834144ClinicalTrials.gov
• Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Colorectal Cancer#850122ClinicalTrials.gov
• Encoded metabolic remodeling amplifies drug resistance in <i>Mycobacterium tuberculosis</i>#455612PLOS
• Mutation, selection, and ancestry in branching models: a variational approach#492702Bielefeld Pub
• Neoadjuvant Camrelizumab and Fluzoparib and Nab-paclitaxel in Early Breast Cancer With HRR Gene Mutation#651230ClinicalTrials.gov
• Niraparib In Recurrent IDH 1/2 Gliomas#835235ClinicalTrials.gov
• Gefitinib and Berberine in the First-line Treatment of Lung Adenocarcinoma With EGFR Mutation#877208ClinicalTrials.gov
• A Study of TAS3351 in NSCLC Patients With EGFRmt#882790ClinicalTrials.gov